Latest News and Press Releases

Dublin, June 03, 2025 (GLOBE NEWSWIRE) -- The "Pollen Allergy - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Pollen Allergy was valued...

Dublin, May 13, 2025 (GLOBE NEWSWIRE) -- The "Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis Market - A Global and Regional Analysis: Focus on Country and Regional Analysis - Analysis...

600-patient study to assess efficacy of rhu-pGSN, an immune system regulator that interrupts the NLRP3 inflammasome and boosts macrophage clearance of pathogens. Results from this landmark study...

New York, April 29, 2025 (GLOBE NEWSWIRE) -- In This Article, You'll Discover: What makes herpes outbreaks (HSV-1 and HSV-2) so challenging to manage long-termWhy traditional herpes treatments...

Dublin, March 14, 2025 (GLOBE NEWSWIRE) -- The "Febrile Neutropenia Market" report has been added to ResearchAndMarkets.com's offering.The global febrile neutropenia market is experiencing robust...

Selbyville, Delaware, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Shingles vaccine market size was valued at USD 4.9 billion in 2024 and is projected to grow at a robust CAGR of 10.1% from 2025 to 2034. Key...

Global 600 patient study will evaluate efficacy and safety of recombinant human plasma gelsolin (rhu-pGSN) for moderate-to-severe ARDS. Rhu-pGSN is an immune system regulator that interrupts the...

NORTH BRUNSWICK, N.J., Sept. 12, 2024 (GLOBE NEWSWIRE) -- BioAegis Therapeutics, a pioneering biotech company at the forefront of innovative therapies for inflammatory diseases, announces that its...

Clinical trial to test recent findings that show LIXTE’s lead clinical compound, LB-100, increases recognition of colon cancer cells by the immune system PASADENA, CA, June 14, 2024 (GLOBE...

GRI’s common stock is expected to begin trading on a post-split adjusted basis on June 18, 2024      LA JOLLA, CA, June 14, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the...